関連する実験動画

Updated: Jan 7, 2026

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

IL‑1受容体拮抗作用はRNF182駆動のMFN2不安定化とミトコンドリア機能障害を介して腎線維化を減弱させる

Bo Yang¹, Qing Shao¹, Wei Wang¹

¹Department of Nephrology, Naval Medical Center of PLA, Naval Medical University, Shanghai, China.

Cell death discovery

|December 29, 2025

まとめ

組換え型ヒトIL-1受容体拮抗薬（rhIL-1Ra）は、IL-1R/RNF182/MFN2経路を標的とすることにより、腎線維症と戦う。この治療法はミトコンドリア機能を維持し、炎症を軽減し、慢性腎臓病（CKD）の潜在的な治療法を提供する。

背景:

腎線維症は慢性腎臓病（CKD）の進行を駆動するが、標的療法は限られている。
インターロイキン-1（IL-1）を介した炎症とミトコンドリア機能障害はCKDに関与しているが、それらの正確な関連は不明である。

結論:

IL-1R/RNF182/MFN2経路は、腎臓における炎症とミトコンドリアおよび線維化病変を結びつける新規の経路である。
RNF182は、線維症におけるミトコンドリア機能障害の主要なメディエーターとして同定された。
rhIL-1Raは、この経路を標的とすることにより、CKDの治療薬としての有望性を示した。

キーワード:

腎線維症ミトコンドリア機能障害 IL-1受容体拮抗薬 RNF182 MFN2 慢性腎臓病

さらに関連する動画

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

関連する概念動画

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...